Your Best Stock
$151.03
−$0.34 (-0.22%)
Market open · Sep 24, 2:00 pm ET
After hours $151.37 0.00%
Open$151.10
Prev close$151.37
Day range$149.69 – $152.97
Volume2.55M
Market cap$187.27B
P/E (TTM)–
Dividend yield2.13%

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$7.80B+10.2% YoY
Operating profit$2.54B-6.8% YoY
Net profit-$10.50B-635.5% YoY
Diluted EPS-$8.45-641.7% YoY
Free cash flow$3.43B+376.8% YoY
Operating cash flow$3.57B

Revenue, last 8 quarters

$7.5BSep '24$7.6BDec '24$6.7BMar '25$7.1BJun '25$7.8BSep '25$7.9BDec '25$7.0BMar '26$7.8BJun '26

Net profit, last 8 quarters

$1.3BSep '24$1.8BDec '24$1.3BMar '25$2.0BJun '25$3.1BSep '25$2.2BDec '25$2.0BMar '26$-10.5BJun '26

Diluted EPS by quarter

1.00Sep '241.42Dec '241.04Mar '251.56Jun '252.43Sep '251.74Dec '251.61Mar '26-8.45Jun '26

Free cash flow by quarter

$4.2BSep '24$2.8BDec '24$1.7BMar '25$720.0MJun '25$4.0BSep '25$3.1BDec '25$2.4BMar '26$3.4BJun '26

Annual revenue

$24.7BFY20$27.3BFY21$27.3BFY22$27.1BFY23$28.8BFY24$29.4BFY25

Profitability & balance sheet

Gross margin79.6%
Operating margin38.5%
Net margin-10.6%
Return on equity-20.6%
Return on assets-6.2%
Return on invested capital-6.9%
Current ratio1.27
Liabilities / assets76.2%
Cash & investments$3.18B
Total debt$26.25B
Net cash (debt)-$23.07B
Free cash flow / sales42.5%

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Biktarvy$3.77B 48.3%
  • Descovy$967.00M 12.4%
  • Other$909.00M 11.6%
  • Trodelvy$457.00M 5.9%
  • Yescarta$346.00M 4.4%
  • Sofosbuvir/Velpatasvir$303.00M 3.9%
  • Vemlidy$289.00M 3.7%
  • Genvoya$289.00M 3.7%
  • Odefsey$239.00M 3.1%
  • Yeztugo$232.00M 3.0%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $7.80B $6.96B $29.44B $7.93B $7.77B
Total Operating Revenue $7.80B $6.96B $29.44B $7.92B $7.77B
Cost of Revenue $1.58B $1.45B $6.23B $1.62B $1.57B
Gross Profit $6.22B $5.52B $23.21B $6.30B $6.20B
Operating Expense $3.69B $2.82B $11.51B $3.31B $2.70B
Selling and Admin Expenses $1.92B $1.45B $5.71B $1.73B $1.36B
-Selling & Marketing Expense $1.01B $898.00M $3.52B $1.08B $829.00M
-General & Admin Expense $910.00M $553.00M $2.19B $652.00M $528.00M
Research & Development $1.76B $1.37B $5.80B $1.58B $1.35B
Operating Profit $2.54B $2.69B $11.70B $2.99B $3.50B
Net Non-Operating Interest Income (Expense) -$202.00M -$145.00M -$675.00M -$160.00M -$168.00M
Non-Operating Interest Income $45.00M $95.00M $349.00M $95.00M $88.00M
Non-Operating Interest Expense $247.00M $240.00M $1.02B $255.00M $256.00M
Other Income (Expense) -$12.59B $33.00M -$1.23B -$750.00M $312.00M
Gain on Sale of Security $343.00M $142.00M $451.00M $253.00M $483.00M
Special Income (Charges) -$12.93B -$107.00M -$1.68B -$1.01B -$170.00M
-Less:Impairment of Capital Assets $1.75B – – – –
-Less:Other Special Charges $11.18B $107.00M $1.02B $539.00M $170.00M
-Less:Write Off $1.75B – $590.00M $400.00M $0.00
Other Non-Operating Income (Expenses) -$1.00M -$2.00M -$1.00M $2.00M -$1.00M
Pretax Profit -$10.25B $2.58B $9.80B $2.08B $3.64B
Tax $242.00M $559.00M $1.29B -$105.00M $589.00M
Net Profit -$10.50B $2.02B $8.51B $2.18B $3.05B
Profit from Continuing Operations -$10.50B $2.02B $8.51B $2.18B $3.05B
Net Income to Parent Company -$10.50B $2.02B $8.51B $2.18B $3.05B
Net Income to Common Stockholders -$10.50B $2.02B $8.51B $2.18B $3.05B
Basic EPS -$8.45 $1.63 $6.84 $1.76 $2.46
Diluted EPS -$8.45 $1.61 $6.78 $1.74 $2.43
Dividend Per Share $0.82 $0.82 $3.16 $0.79 $0.79
-Less:Restructuring and Mergern & Acquisition – – $66.00M – –
Minority Interests – – $0.00 $0.00 $0.00

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $49.36B $56.28B $59.02B $59.02B $58.53B
Total Current Assets $13.95B $18.64B $18.34B $18.34B $17.87B
Cash and Cash Equivalents & Short-Term Investments $3.18B $7.64B $9.61B $9.61B $7.35B
-Cash and Cash Equivalents $3.18B $7.63B $7.56B $7.56B $7.33B
-Short Term Investments $0.00 $15.00M $2.05B $2.05B $19.00M
Receivables $5.06B $4.74B $4.91B $4.91B $5.10B
-Accounts Receivable $5.06B $4.74B $4.91B $4.91B $5.10B
Inventory $1.95B $1.91B $1.77B $1.77B $1.79B
Other Current Assets $3.76B $4.34B $1.14B $1.14B $3.65B
Total Non-Current Assets $35.42B $37.64B $40.68B $40.68B $40.66B
Net PPE $5.83B $5.64B $5.61B $5.61B $5.50B
-Gross PPE $8.71B $8.42B $8.30B $8.30B $8.19B
-Accumulated Depreciation -$2.87B -$2.78B -$2.70B -$2.70B -$2.69B
Investments and Advances $0.00 $983.00M $2.97B $2.97B $2.01B
Goodwill and Other Intangible Assets $22.35B $24.70B $25.29B $25.29B $26.28B
-Goodwill $8.31B $8.31B $8.31B $8.31B $8.31B
-Other Intangible Assets $14.03B $16.38B $16.98B $16.98B $17.97B
Non-Current Deferred Assets $2.49B $1.77B $1.96B $1.96B $2.00B
Other Non-Current Assets $4.75B $4.55B $4.85B $4.85B $4.87B
Total Liabilities $37.62B $32.85B $36.41B $36.41B $37.08B
Total Current Liabilities $11.02B $9.48B $11.81B $11.81B $12.30B
Payables $674.00M $645.00M $807.00M $807.00M $808.00M
-Accounts Payable $674.00M $645.00M $715.00M $715.00M $808.00M
Current Accrued Expenses $4.23B $4.12B $4.34B $4.34B $4.93B
Short-Term Debt and Capital Lease Obligation $2.41B $1.31B $2.81B $2.81B $2.81B
-Current Debt $2.41B $1.31B $2.81B $2.81B $2.81B
Other Current Liabilities $3.70B $3.40B $2.24B $2.24B $3.75B
Total Non-Current Liabilities $26.60B $23.37B $24.59B $24.59B $24.78B
Long Term Accounts Payable and Other Payables $943.00M $918.00M $896.00M $896.00M $866.00M
Long Term Debt and Capital Lease Obligation $23.83B $20.86B $22.13B $22.13B $22.14B
-Long Term Debt $23.83B $20.86B $22.13B $22.13B $22.14B
Non-Current Deferred Liabilities $333.00M $392.00M $402.00M $402.00M $597.00M
Other Non-Current Liabilities $1.49B $1.20B $1.17B $1.17B $1.18B
Total Equity $11.74B $23.43B $22.62B $22.62B $21.46B
Stockholders' Equity $11.83B $23.52B $22.70B $22.70B $21.54B
Capital Stock $1.00M $1.00M $1.00M $1.00M $1.00M
-Common Stock $1.00M $1.00M $1.00M $1.00M $1.00M
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $9.53B $9.31B $8.93B $8.93B $8.68B
Retained Earnings $2.20B $14.13B $13.73B $13.73B $12.83B
Gains/Losses Not Affecting Retained Earnings $95.00M $78.00M $39.00M $39.00M $36.00M
Minority Interests -$84.00M -$84.00M -$84.00M -$84.00M -$84.00M
-Available for Sale Securities – $983.00M $2.97B $2.97B $2.01B
Prepaid Assets – – $899.00M $899.00M –
-Total Tax Payable – – $92.00M $92.00M –
Current Provisions – – $321.00M $321.00M –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $3.57B $2.54B $10.02B $3.33B $4.11B
Net cash flow from continuing operations $3.57B $2.54B $10.02B $3.33B $4.11B
Net Income from Continuing Operations -$10.50B $2.02B $8.51B $2.18B $3.05B
Gain/Loss from Continuing Operations -$343.00M -$142.00M -$451.00M -$253.00M -$482.00M
Depreciation & Depletion & Amortization $698.00M $689.00M $2.76B $687.00M $686.00M
Deferred Tax -$587.00M $179.00M $160.00M -$122.00M $659.00M
Other Non-Cash Items $12.28B $290.00M $1.50B $806.00M $260.00M
Change in Working Capital $36.00M -$711.00M -$3.95B -$604.00M -$297.00M
-Change in Receivables -$333.00M $134.00M -$367.00M $179.00M -$333.00M
-Change in Inventory -$145.00M -$52.00M -$1.04B -$123.00M -$515.00M
-Change in Prepaid Assets -$13.00M $5.00M -$311.00M -$36.00M -$368.00M
-Change in Payables and Accrued Expense $356.00M -$769.00M -$126.00M -$490.00M $1.04B
-Change In Other Working Capital $171.00M -$29.00M -$2.11B -$134.00M -$122.00M
Net cash flow from investing -$10.35B $1.77B -$4.79B -$1.84B -$427.00M
Net Cash Flow from Continuing Investing Activities -$10.35B $1.77B -$4.79B -$1.84B -$426.00M
Net PPE Purchase and Sale -$140.00M -$117.00M -$563.00M -$205.00M -$147.00M
Net Business Purchase and Sale -$11.21B -$109.00M -$1.07B -$609.00M -$167.00M
Net Investment Purchase and Sale $983.00M $2.01B -$3.16B -$1.03B -$116.00M
Net Other Investing Changes $19.00M -$16.00M $3.00M $12.00M $3.00M
Financing Cash Flow $2.34B -$4.24B -$7.75B -$1.26B -$1.49B
Net Cash Flow from Continuing Financing Activities $2.34B -$4.24B -$7.75B -$1.26B -$1.49B
Net Issuance Payments Of Debt $4.07B -$2.77B -$1.79B -$8.00M -$9.00M
Net Common Stock Issuance -$346.00M -$253.00M -$1.51B -$198.00M -$338.00M
Cash Dividends Paid -$1.03B -$1.04B -$4.00B -$994.00M -$1.01B
Net Other Financing Charges -$349.00M -$180.00M -$440.00M -$63.00M -$137.00M
Ending Cash Balance $3.18B $7.63B $7.56B $7.56B $7.33B
Net Change in Cash -$4.43B $75.00M -$2.52B $229.00M $2.19B
Beginning Cash Balance $7.63B $7.56B $9.99B $7.33B $5.14B
Effect of Exchange Rate Changes -$19.00M -$11.00M $92.00M $5.00M -$5.00M
Free Cash Flow $3.43B $2.43B $9.46B $3.12B $3.96B
Scroll to Top